Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × spartalizumab × Sarcoma × Clear all

Phase

Status

Completed 4 Terminated 3 Withdrawn 1 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21 Head & Neck 10 Thoracic 6 Other solid neoplasm 6 Gynecologic 3 Dermatologic 3 CNS 3 Lymphoid 2 Genitourinary 2 Breast 2 Sarcoma 1

Conditions

Sarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1

Interventions

Doxorubicin 25 Specimen Handling 19 Cyclophosphamide 19 Temozolomide 17 pembrolizumab 16 Biopsy 14 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Gemcitabine 13 Blood Specimen Collection 12 atezolizumab 11 fludarabine 10 Vincristine 10 Radiotherapy 10 Ifosfamide 9 Irinotecan 8 Drug Therapy 8 Trabectedin 7 Nivolumab 7 cabozantinib 6 X-Rays 6 Surveys and Questionnaires 6 Radiation 6 Imatinib Mesylate 6 Sunitinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Dactinomycin 5 Cisplatin 5 selinexor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05961761 2023-07-27

PROPANE

Herlev and Gentofte Hospital

Phase 2 Recruiting

Hemangiosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡